Global Elrantamab Supply, Demand and Key Producers, 2026-2032
The global Elrantamab market size is expected to reach $ 1153 million by 2032, rising at a market growth of 12.6% CAGR during the forecast period (2026-2032).
Elranatamab is a humanized bispecific monoclonal antibody targeting BCMA/CD3, indicated for the treatment of relapsed or refractory multiple myeloma. The drug can simultaneously bind to BCMA antigen on the surface of myeloma cells and CD3 antigen on the surface of T cells. By bridging tumor cells and T cells, it activates T cells to specifically kill tumor cells. As a T-cell redirecting immunotherapeutic agent, it is characterized by high targeting specificity and significant anti-tumor activity.In 2025, global Elranatamab production reached approximately 51000??52000 vials.
Elranatamab is a humanized bispecific monoclonal antibody targeting BCMA/CD3, mainly used for the treatment of relapsed or refractory multiple myeloma, and is one of the core agents in the field of T-cell redirecting immunotherapy. With a clear mechanism of action, it activates anti-tumor immunity by bridging myeloma cells and T cells. Clinical studies have confirmed that it exhibits deep and durable efficacy in heavily pretreated patients, and is recommended by authoritative guidelines such as the US NCCN and Chinese CSCO, with a clear market positioning.
In terms of the competitive landscape, the drug, together with similar BCMA/CD3 bispecific antibodies including Johnson & Johnson?s Teclistamab, constitutes an important therapeutic option for multiple myeloma, while facing competition from CAR-T therapies. Its differentiation is reflected in its administration route and tolerability profile. Elranatamab has been approved in major markets worldwide including the United States, the European Union and China, with commercial layout covering multiple regions. Continuous clinical development, including combination therapies and exploration of first-line indications, provides long-term momentum for market expansion.
As an important layout of Pfizer in the field of tumor immunology, the drug relies on the company?s marketing channels and R&D resources, and is expected to occupy an important position in the bispecific antibody market for multiple myeloma. Meanwhile, it will promote the popularization and application of BCMA-targeted therapeutic regimens and become a key force in innovating the treatment landscape of this field.
This report studies the global Elrantamab production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Elrantamab and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Elrantamab that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Elrantamab total production and demand, 2021-2032, (Units)
Global Elrantamab total production value, 2021-2032, (USD Million)
Global Elrantamab production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Elrantamab consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Elrantamab domestic production, consumption, key domestic manufacturers and share
Global Elrantamab production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Elrantamab production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Elrantamab production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Elrantamab market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Elrantamab market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Elrantamab Market, By Region:
1. How big is the global Elrantamab market?
2. What is the demand of the global Elrantamab market?
3. What is the year over year growth of the global Elrantamab market?
4. What is the production and production value of the global Elrantamab market?
5. Who are the key producers in the global Elrantamab market?
6. What are the growth factors driving the market demand?
Elranatamab is a humanized bispecific monoclonal antibody targeting BCMA/CD3, indicated for the treatment of relapsed or refractory multiple myeloma. The drug can simultaneously bind to BCMA antigen on the surface of myeloma cells and CD3 antigen on the surface of T cells. By bridging tumor cells and T cells, it activates T cells to specifically kill tumor cells. As a T-cell redirecting immunotherapeutic agent, it is characterized by high targeting specificity and significant anti-tumor activity.In 2025, global Elranatamab production reached approximately 51000??52000 vials.
Elranatamab is a humanized bispecific monoclonal antibody targeting BCMA/CD3, mainly used for the treatment of relapsed or refractory multiple myeloma, and is one of the core agents in the field of T-cell redirecting immunotherapy. With a clear mechanism of action, it activates anti-tumor immunity by bridging myeloma cells and T cells. Clinical studies have confirmed that it exhibits deep and durable efficacy in heavily pretreated patients, and is recommended by authoritative guidelines such as the US NCCN and Chinese CSCO, with a clear market positioning.
In terms of the competitive landscape, the drug, together with similar BCMA/CD3 bispecific antibodies including Johnson & Johnson?s Teclistamab, constitutes an important therapeutic option for multiple myeloma, while facing competition from CAR-T therapies. Its differentiation is reflected in its administration route and tolerability profile. Elranatamab has been approved in major markets worldwide including the United States, the European Union and China, with commercial layout covering multiple regions. Continuous clinical development, including combination therapies and exploration of first-line indications, provides long-term momentum for market expansion.
As an important layout of Pfizer in the field of tumor immunology, the drug relies on the company?s marketing channels and R&D resources, and is expected to occupy an important position in the bispecific antibody market for multiple myeloma. Meanwhile, it will promote the popularization and application of BCMA-targeted therapeutic regimens and become a key force in innovating the treatment landscape of this field.
This report studies the global Elrantamab production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Elrantamab and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Elrantamab that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Elrantamab total production and demand, 2021-2032, (Units)
Global Elrantamab total production value, 2021-2032, (USD Million)
Global Elrantamab production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Elrantamab consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Elrantamab domestic production, consumption, key domestic manufacturers and share
Global Elrantamab production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Elrantamab production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Elrantamab production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Elrantamab market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Elrantamab market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Elrantamab Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 44 mg / 1.1 mL
- 76 mg / 1.9 mL
- Subcutaneous Injection Solution
- Lyophilized Powder for Injection
- Hospital
- Retail
- Online
- Monoclonal Antibody
- Polyclonal Antibody
- Bispecific Antibody
- Monotherapy for Relapsed or Refractory Multiple Myeloma
- Combination Therapy with Immunomodulators and Proteasome Inhibitors
- Exploration in First-Line or Second-Line Treatment of Multiple Myeloma
- Otherts
- Pfizer
1. How big is the global Elrantamab market?
2. What is the demand of the global Elrantamab market?
3. What is the year over year growth of the global Elrantamab market?
4. What is the production and production value of the global Elrantamab market?
5. Who are the key producers in the global Elrantamab market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Elrantamab Introduction
1.2 World Elrantamab Supply & Forecast
1.2.1 World Elrantamab Production Value (2021 & 2025 & 2032)
1.2.2 World Elrantamab Production (2021-2032)
1.2.3 World Elrantamab Pricing Trends (2021-2032)
1.3 World Elrantamab Production by Region (Based on Production Site)
1.3.1 World Elrantamab Production Value by Region (2021-2032)
1.3.2 World Elrantamab Production by Region (2021-2032)
1.3.3 World Elrantamab Average Price by Region (2021-2032)
1.3.4 North America Elrantamab Production (2021-2032)
1.3.5 Europe Elrantamab Production (2021-2032)
1.3.6 China Elrantamab Production (2021-2032)
1.3.7 Japan Elrantamab Production (2021-2032)
1.3.8 India Elrantamab Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Elrantamab Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Elrantamab Major Market Trends
2 DEMAND SUMMARY
2.1 World Elrantamab Demand (2021-2032)
2.2 World Elrantamab Consumption by Region
2.2.1 World Elrantamab Consumption by Region (2021-2026)
2.2.2 World Elrantamab Consumption Forecast by Region (2027-2032)
2.3 United States Elrantamab Consumption (2021-2032)
2.4 China Elrantamab Consumption (2021-2032)
2.5 Europe Elrantamab Consumption (2021-2032)
2.6 Japan Elrantamab Consumption (2021-2032)
2.7 South Korea Elrantamab Consumption (2021-2032)
2.8 ASEAN Elrantamab Consumption (2021-2032)
2.9 India Elrantamab Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Elrantamab Production Value by Manufacturer (2021-2026)
3.2 World Elrantamab Production by Manufacturer (2021-2026)
3.3 World Elrantamab Average Price by Manufacturer (2021-2026)
3.4 Elrantamab Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Elrantamab Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Elrantamab in 2025
3.5.3 Global Concentration Ratios (CR8) for Elrantamab in 2025
3.6 Elrantamab Market: Overall Company Footprint Analysis
3.6.1 Elrantamab Market: Region Footprint
3.6.2 Elrantamab Market: Company Product Type Footprint
3.6.3 Elrantamab Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Elrantamab Production Value Comparison
4.1.1 United States VS China: Elrantamab Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Elrantamab Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Elrantamab Production Comparison
4.2.1 United States VS China: Elrantamab Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Elrantamab Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Elrantamab Consumption Comparison
4.3.1 United States VS China: Elrantamab Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Elrantamab Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Elrantamab Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Elrantamab Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Elrantamab Production Value (2021-2026)
4.4.3 United States Based Manufacturers Elrantamab Production (2021-2026)
4.5 China Based Elrantamab Manufacturers and Market Share
4.5.1 China Based Elrantamab Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Elrantamab Production Value (2021-2026)
4.5.3 China Based Manufacturers Elrantamab Production (2021-2026)
4.6 Rest of World Based Elrantamab Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Elrantamab Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Elrantamab Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Elrantamab Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Elrantamab Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 44 mg / 1.1 mL
5.2.2 76 mg / 1.9 mL
5.3 Market Segment by Type
5.3.1 World Elrantamab Production by Type (2021-2032)
5.3.2 World Elrantamab Production Value by Type (2021-2032)
5.3.3 World Elrantamab Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DOSAGE FORM
6.1 World Elrantamab Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage Form
6.2.1 Subcutaneous Injection Solution
6.2.2 Lyophilized Powder for Injection
6.3 Market Segment by Dosage Form
6.3.1 World Elrantamab Production by Dosage Form (2021-2032)
6.3.2 World Elrantamab Production Value by Dosage Form (2021-2032)
6.3.3 World Elrantamab Average Price by Dosage Form (2021-2032)
7 MARKET ANALYSIS BY SALES CHANNELS
7.1 World Elrantamab Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sales Channels
7.2.1 Hospital
7.2.2 Retail
7.2.3 Online
7.3 Market Segment by Sales Channels
7.3.1 World Elrantamab Production by Sales Channels (2021-2032)
7.3.2 World Elrantamab Production Value by Sales Channels (2021-2032)
7.3.3 World Elrantamab Average Price by Sales Channels (2021-2032)
8 MARKET ANALYSIS BY ANTIBODY TYPE
8.1 World Elrantamab Market Size Overview by Antibody Type: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Antibody Type
8.2.1 Monoclonal Antibody
8.2.2 Polyclonal Antibody
8.2.3 Bispecific Antibody
8.3 Market Segment by Antibody Type
8.3.1 World Elrantamab Production by Antibody Type (2021-2032)
8.3.2 World Elrantamab Production Value by Antibody Type (2021-2032)
8.3.3 World Elrantamab Average Price by Antibody Type (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Elrantamab Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Monotherapy for Relapsed or Refractory Multiple Myeloma
9.2.2 Combination Therapy with Immunomodulators and Proteasome Inhibitors
9.2.3 Exploration in First-Line or Second-Line Treatment of Multiple Myeloma
9.2.4 Otherts
9.3 Market Segment by Application
9.3.1 World Elrantamab Production by Application (2021-2032)
9.3.2 World Elrantamab Production Value by Application (2021-2032)
9.3.3 World Elrantamab Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Pfizer
10.1.1 Pfizer Details
10.1.2 Pfizer Major Business
10.1.3 Pfizer Elrantamab Product and Services
10.1.4 Pfizer Elrantamab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Pfizer Recent Developments/Updates
10.1.6 Pfizer Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Elrantamab Industry Chain
11.2 Elrantamab Upstream Analysis
11.2.1 Elrantamab Core Raw Materials
11.2.2 Main Manufacturers of Elrantamab Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Elrantamab Production Mode
11.6 Elrantamab Procurement Model
11.7 Elrantamab Industry Sales Model and Sales Channels
11.7.1 Elrantamab Sales Model
11.7.2 Elrantamab Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Elrantamab Introduction
1.2 World Elrantamab Supply & Forecast
1.2.1 World Elrantamab Production Value (2021 & 2025 & 2032)
1.2.2 World Elrantamab Production (2021-2032)
1.2.3 World Elrantamab Pricing Trends (2021-2032)
1.3 World Elrantamab Production by Region (Based on Production Site)
1.3.1 World Elrantamab Production Value by Region (2021-2032)
1.3.2 World Elrantamab Production by Region (2021-2032)
1.3.3 World Elrantamab Average Price by Region (2021-2032)
1.3.4 North America Elrantamab Production (2021-2032)
1.3.5 Europe Elrantamab Production (2021-2032)
1.3.6 China Elrantamab Production (2021-2032)
1.3.7 Japan Elrantamab Production (2021-2032)
1.3.8 India Elrantamab Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Elrantamab Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Elrantamab Major Market Trends
2 DEMAND SUMMARY
2.1 World Elrantamab Demand (2021-2032)
2.2 World Elrantamab Consumption by Region
2.2.1 World Elrantamab Consumption by Region (2021-2026)
2.2.2 World Elrantamab Consumption Forecast by Region (2027-2032)
2.3 United States Elrantamab Consumption (2021-2032)
2.4 China Elrantamab Consumption (2021-2032)
2.5 Europe Elrantamab Consumption (2021-2032)
2.6 Japan Elrantamab Consumption (2021-2032)
2.7 South Korea Elrantamab Consumption (2021-2032)
2.8 ASEAN Elrantamab Consumption (2021-2032)
2.9 India Elrantamab Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Elrantamab Production Value by Manufacturer (2021-2026)
3.2 World Elrantamab Production by Manufacturer (2021-2026)
3.3 World Elrantamab Average Price by Manufacturer (2021-2026)
3.4 Elrantamab Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Elrantamab Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Elrantamab in 2025
3.5.3 Global Concentration Ratios (CR8) for Elrantamab in 2025
3.6 Elrantamab Market: Overall Company Footprint Analysis
3.6.1 Elrantamab Market: Region Footprint
3.6.2 Elrantamab Market: Company Product Type Footprint
3.6.3 Elrantamab Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Elrantamab Production Value Comparison
4.1.1 United States VS China: Elrantamab Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Elrantamab Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Elrantamab Production Comparison
4.2.1 United States VS China: Elrantamab Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Elrantamab Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Elrantamab Consumption Comparison
4.3.1 United States VS China: Elrantamab Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Elrantamab Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Elrantamab Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Elrantamab Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Elrantamab Production Value (2021-2026)
4.4.3 United States Based Manufacturers Elrantamab Production (2021-2026)
4.5 China Based Elrantamab Manufacturers and Market Share
4.5.1 China Based Elrantamab Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Elrantamab Production Value (2021-2026)
4.5.3 China Based Manufacturers Elrantamab Production (2021-2026)
4.6 Rest of World Based Elrantamab Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Elrantamab Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Elrantamab Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Elrantamab Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Elrantamab Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 44 mg / 1.1 mL
5.2.2 76 mg / 1.9 mL
5.3 Market Segment by Type
5.3.1 World Elrantamab Production by Type (2021-2032)
5.3.2 World Elrantamab Production Value by Type (2021-2032)
5.3.3 World Elrantamab Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DOSAGE FORM
6.1 World Elrantamab Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage Form
6.2.1 Subcutaneous Injection Solution
6.2.2 Lyophilized Powder for Injection
6.3 Market Segment by Dosage Form
6.3.1 World Elrantamab Production by Dosage Form (2021-2032)
6.3.2 World Elrantamab Production Value by Dosage Form (2021-2032)
6.3.3 World Elrantamab Average Price by Dosage Form (2021-2032)
7 MARKET ANALYSIS BY SALES CHANNELS
7.1 World Elrantamab Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sales Channels
7.2.1 Hospital
7.2.2 Retail
7.2.3 Online
7.3 Market Segment by Sales Channels
7.3.1 World Elrantamab Production by Sales Channels (2021-2032)
7.3.2 World Elrantamab Production Value by Sales Channels (2021-2032)
7.3.3 World Elrantamab Average Price by Sales Channels (2021-2032)
8 MARKET ANALYSIS BY ANTIBODY TYPE
8.1 World Elrantamab Market Size Overview by Antibody Type: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Antibody Type
8.2.1 Monoclonal Antibody
8.2.2 Polyclonal Antibody
8.2.3 Bispecific Antibody
8.3 Market Segment by Antibody Type
8.3.1 World Elrantamab Production by Antibody Type (2021-2032)
8.3.2 World Elrantamab Production Value by Antibody Type (2021-2032)
8.3.3 World Elrantamab Average Price by Antibody Type (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Elrantamab Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Monotherapy for Relapsed or Refractory Multiple Myeloma
9.2.2 Combination Therapy with Immunomodulators and Proteasome Inhibitors
9.2.3 Exploration in First-Line or Second-Line Treatment of Multiple Myeloma
9.2.4 Otherts
9.3 Market Segment by Application
9.3.1 World Elrantamab Production by Application (2021-2032)
9.3.2 World Elrantamab Production Value by Application (2021-2032)
9.3.3 World Elrantamab Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Pfizer
10.1.1 Pfizer Details
10.1.2 Pfizer Major Business
10.1.3 Pfizer Elrantamab Product and Services
10.1.4 Pfizer Elrantamab Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Pfizer Recent Developments/Updates
10.1.6 Pfizer Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Elrantamab Industry Chain
11.2 Elrantamab Upstream Analysis
11.2.1 Elrantamab Core Raw Materials
11.2.2 Main Manufacturers of Elrantamab Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Elrantamab Production Mode
11.6 Elrantamab Procurement Model
11.7 Elrantamab Industry Sales Model and Sales Channels
11.7.1 Elrantamab Sales Model
11.7.2 Elrantamab Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World Elrantamab Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Elrantamab Production Value by Region (2021-2026) & (USD Million)
Table 3. World Elrantamab Production Value by Region (2027-2032) & (USD Million)
Table 4. World Elrantamab Production Value Market Share by Region (2021-2026)
Table 5. World Elrantamab Production Value Market Share by Region (2027-2032)
Table 6. World Elrantamab Production by Region (2021-2026) & (Units)
Table 7. World Elrantamab Production by Region (2027-2032) & (Units)
Table 8. World Elrantamab Production Market Share by Region (2021-2026)
Table 9. World Elrantamab Production Market Share by Region (2027-2032)
Table 10. World Elrantamab Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Elrantamab Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Elrantamab Major Market Trends
Table 13. World Elrantamab Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Elrantamab Consumption by Region (2021-2026) & (Units)
Table 15. World Elrantamab Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Elrantamab Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Elrantamab Producers in 2025
Table 18. World Elrantamab Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Elrantamab Producers in 2025
Table 20. World Elrantamab Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Elrantamab Company Evaluation Quadrant
Table 22. World Elrantamab Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Elrantamab Production Site of Key Manufacturer
Table 24. Elrantamab Market: Company Product Type Footprint
Table 25. Elrantamab Market: Company Product Application Footprint
Table 26. Elrantamab Competitive Factors
Table 27. Elrantamab New Entrant and Capacity Expansion Plans
Table 28. Elrantamab Mergers & Acquisitions Activity
Table 29. United States VS China Elrantamab Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Elrantamab Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Elrantamab Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Elrantamab Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Elrantamab Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Elrantamab Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Elrantamab Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Elrantamab Production Market Share (2021-2026)
Table 37. China Based Elrantamab Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Elrantamab Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Elrantamab Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Elrantamab Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Elrantamab Production Market Share (2021-2026)
Table 42. Rest of World Based Elrantamab Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Elrantamab Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Elrantamab Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Elrantamab Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Elrantamab Production Market Share (2021-2026)
Table 47. World Elrantamab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Elrantamab Production by Type (2021-2026) & (Units)
Table 49. World Elrantamab Production by Type (2027-2032) & (Units)
Table 50. World Elrantamab Production Value by Type (2021-2026) & (USD Million)
Table 51. World Elrantamab Production Value by Type (2027-2032) & (USD Million)
Table 52. World Elrantamab Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Elrantamab Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Elrantamab Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 55. World Elrantamab Production by Dosage Form (2021-2026) & (Units)
Table 56. World Elrantamab Production by Dosage Form (2027-2032) & (Units)
Table 57. World Elrantamab Production Value by Dosage Form (2021-2026) & (USD Million)
Table 58. World Elrantamab Production Value by Dosage Form (2027-2032) & (USD Million)
Table 59. World Elrantamab Average Price by Dosage Form (2021-2026) & (US$/Unit)
Table 60. World Elrantamab Average Price by Dosage Form (2027-2032) & (US$/Unit)
Table 61. World Elrantamab Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 62. World Elrantamab Production by Sales Channels (2021-2026) & (Units)
Table 63. World Elrantamab Production by Sales Channels (2027-2032) & (Units)
Table 64. World Elrantamab Production Value by Sales Channels (2021-2026) & (USD Million)
Table 65. World Elrantamab Production Value by Sales Channels (2027-2032) & (USD Million)
Table 66. World Elrantamab Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 67. World Elrantamab Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 68. World Elrantamab Production Value by Antibody Type, (USD Million), 2021 & 2025 & 2032
Table 69. World Elrantamab Production by Antibody Type (2021-2026) & (Units)
Table 70. World Elrantamab Production by Antibody Type (2027-2032) & (Units)
Table 71. World Elrantamab Production Value by Antibody Type (2021-2026) & (USD Million)
Table 72. World Elrantamab Production Value by Antibody Type (2027-2032) & (USD Million)
Table 73. World Elrantamab Average Price by Antibody Type (2021-2026) & (US$/Unit)
Table 74. World Elrantamab Average Price by Antibody Type (2027-2032) & (US$/Unit)
Table 75. World Elrantamab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Elrantamab Production by Application (2021-2026) & (Units)
Table 77. World Elrantamab Production by Application (2027-2032) & (Units)
Table 78. World Elrantamab Production Value by Application (2021-2026) & (USD Million)
Table 79. World Elrantamab Production Value by Application (2027-2032) & (USD Million)
Table 80. World Elrantamab Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Elrantamab Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Pfizer Basic Information, Manufacturing Base and Competitors
Table 83. Pfizer Major Business
Table 84. Pfizer Elrantamab Product and Services
Table 85. Pfizer Elrantamab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Pfizer Recent Developments/Updates
Table 87. Pfizer Competitive Strengths & Weaknesses
Table 88. Global Key Players of Elrantamab Upstream (Raw Materials)
Table 89. Global Elrantamab Typical Customers
Table 90. Elrantamab Typical Distributors
Table 1. World Elrantamab Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Elrantamab Production Value by Region (2021-2026) & (USD Million)
Table 3. World Elrantamab Production Value by Region (2027-2032) & (USD Million)
Table 4. World Elrantamab Production Value Market Share by Region (2021-2026)
Table 5. World Elrantamab Production Value Market Share by Region (2027-2032)
Table 6. World Elrantamab Production by Region (2021-2026) & (Units)
Table 7. World Elrantamab Production by Region (2027-2032) & (Units)
Table 8. World Elrantamab Production Market Share by Region (2021-2026)
Table 9. World Elrantamab Production Market Share by Region (2027-2032)
Table 10. World Elrantamab Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Elrantamab Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Elrantamab Major Market Trends
Table 13. World Elrantamab Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Elrantamab Consumption by Region (2021-2026) & (Units)
Table 15. World Elrantamab Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Elrantamab Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Elrantamab Producers in 2025
Table 18. World Elrantamab Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Elrantamab Producers in 2025
Table 20. World Elrantamab Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Elrantamab Company Evaluation Quadrant
Table 22. World Elrantamab Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Elrantamab Production Site of Key Manufacturer
Table 24. Elrantamab Market: Company Product Type Footprint
Table 25. Elrantamab Market: Company Product Application Footprint
Table 26. Elrantamab Competitive Factors
Table 27. Elrantamab New Entrant and Capacity Expansion Plans
Table 28. Elrantamab Mergers & Acquisitions Activity
Table 29. United States VS China Elrantamab Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Elrantamab Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Elrantamab Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Elrantamab Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Elrantamab Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Elrantamab Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Elrantamab Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Elrantamab Production Market Share (2021-2026)
Table 37. China Based Elrantamab Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Elrantamab Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Elrantamab Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Elrantamab Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Elrantamab Production Market Share (2021-2026)
Table 42. Rest of World Based Elrantamab Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Elrantamab Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Elrantamab Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Elrantamab Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Elrantamab Production Market Share (2021-2026)
Table 47. World Elrantamab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Elrantamab Production by Type (2021-2026) & (Units)
Table 49. World Elrantamab Production by Type (2027-2032) & (Units)
Table 50. World Elrantamab Production Value by Type (2021-2026) & (USD Million)
Table 51. World Elrantamab Production Value by Type (2027-2032) & (USD Million)
Table 52. World Elrantamab Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Elrantamab Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Elrantamab Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 55. World Elrantamab Production by Dosage Form (2021-2026) & (Units)
Table 56. World Elrantamab Production by Dosage Form (2027-2032) & (Units)
Table 57. World Elrantamab Production Value by Dosage Form (2021-2026) & (USD Million)
Table 58. World Elrantamab Production Value by Dosage Form (2027-2032) & (USD Million)
Table 59. World Elrantamab Average Price by Dosage Form (2021-2026) & (US$/Unit)
Table 60. World Elrantamab Average Price by Dosage Form (2027-2032) & (US$/Unit)
Table 61. World Elrantamab Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 62. World Elrantamab Production by Sales Channels (2021-2026) & (Units)
Table 63. World Elrantamab Production by Sales Channels (2027-2032) & (Units)
Table 64. World Elrantamab Production Value by Sales Channels (2021-2026) & (USD Million)
Table 65. World Elrantamab Production Value by Sales Channels (2027-2032) & (USD Million)
Table 66. World Elrantamab Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 67. World Elrantamab Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 68. World Elrantamab Production Value by Antibody Type, (USD Million), 2021 & 2025 & 2032
Table 69. World Elrantamab Production by Antibody Type (2021-2026) & (Units)
Table 70. World Elrantamab Production by Antibody Type (2027-2032) & (Units)
Table 71. World Elrantamab Production Value by Antibody Type (2021-2026) & (USD Million)
Table 72. World Elrantamab Production Value by Antibody Type (2027-2032) & (USD Million)
Table 73. World Elrantamab Average Price by Antibody Type (2021-2026) & (US$/Unit)
Table 74. World Elrantamab Average Price by Antibody Type (2027-2032) & (US$/Unit)
Table 75. World Elrantamab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Elrantamab Production by Application (2021-2026) & (Units)
Table 77. World Elrantamab Production by Application (2027-2032) & (Units)
Table 78. World Elrantamab Production Value by Application (2021-2026) & (USD Million)
Table 79. World Elrantamab Production Value by Application (2027-2032) & (USD Million)
Table 80. World Elrantamab Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Elrantamab Average Price by Application (2027-2032) & (US$/Unit)
Table 82. Pfizer Basic Information, Manufacturing Base and Competitors
Table 83. Pfizer Major Business
Table 84. Pfizer Elrantamab Product and Services
Table 85. Pfizer Elrantamab Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Pfizer Recent Developments/Updates
Table 87. Pfizer Competitive Strengths & Weaknesses
Table 88. Global Key Players of Elrantamab Upstream (Raw Materials)
Table 89. Global Elrantamab Typical Customers
Table 90. Elrantamab Typical Distributors
LIST OF FIGURES
Figure 1. Elrantamab Picture
Figure 2. World Elrantamab Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Elrantamab Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Elrantamab Production (2021-2032) & (Units)
Figure 5. World Elrantamab Average Price (2021-2032) & (US$/Unit)
Figure 6. World Elrantamab Production Value Market Share by Region (2021-2032)
Figure 7. World Elrantamab Production Market Share by Region (2021-2032)
Figure 8. North America Elrantamab Production (2021-2032) & (Units)
Figure 9. Europe Elrantamab Production (2021-2032) & (Units)
Figure 10. China Elrantamab Production (2021-2032) & (Units)
Figure 11. Japan Elrantamab Production (2021-2032) & (Units)
Figure 12. India Elrantamab Production (2021-2032) & (Units)
Figure 13. Elrantamab Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Elrantamab Consumption (2021-2032) & (Units)
Figure 16. World Elrantamab Consumption Market Share by Region (2021-2032)
Figure 17. United States Elrantamab Consumption (2021-2032) & (Units)
Figure 18. China Elrantamab Consumption (2021-2032) & (Units)
Figure 19. Europe Elrantamab Consumption (2021-2032) & (Units)
Figure 20. Japan Elrantamab Consumption (2021-2032) & (Units)
Figure 21. South Korea Elrantamab Consumption (2021-2032) & (Units)
Figure 22. ASEAN Elrantamab Consumption (2021-2032) & (Units)
Figure 23. India Elrantamab Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Elrantamab by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Elrantamab Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Elrantamab Markets in 2025
Figure 27. United States VS China: Elrantamab Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Elrantamab Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Elrantamab Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Elrantamab Production Market Share 2025
Figure 31. China Based Manufacturers Elrantamab Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Elrantamab Production Market Share 2025
Figure 33. World Elrantamab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Elrantamab Production Value Market Share by Type in 2025
Figure 35. 44 mg / 1.1 mL
Figure 36. 76 mg / 1.9 mL
Figure 37. World Elrantamab Production Market Share by Type (2021-2032)
Figure 38. World Elrantamab Production Value Market Share by Type (2021-2032)
Figure 39. World Elrantamab Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Elrantamab Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 41. World Elrantamab Production Value Market Share by Dosage Form in 2025
Figure 42. Subcutaneous Injection Solution
Figure 43. Lyophilized Powder for Injection
Figure 44. World Elrantamab Production Market Share by Dosage Form (2021-2032)
Figure 45. World Elrantamab Production Value Market Share by Dosage Form (2021-2032)
Figure 46. World Elrantamab Average Price by Dosage Form (2021-2032) & (US$/Unit)
Figure 47. World Elrantamab Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 48. World Elrantamab Production Value Market Share by Sales Channels in 2025
Figure 49. Hospital
Figure 50. Retail
Figure 51. Online
Figure 52. World Elrantamab Production Market Share by Sales Channels (2021-2032)
Figure 53. World Elrantamab Production Value Market Share by Sales Channels (2021-2032)
Figure 54. World Elrantamab Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 55. World Elrantamab Production Value by Antibody Type, (USD Million), 2021 & 2025 & 2032
Figure 56. World Elrantamab Production Value Market Share by Antibody Type in 2025
Figure 57. Monoclonal Antibody
Figure 58. Polyclonal Antibody
Figure 59. Bispecific Antibody
Figure 60. World Elrantamab Production Market Share by Antibody Type (2021-2032)
Figure 61. World Elrantamab Production Value Market Share by Antibody Type (2021-2032)
Figure 62. World Elrantamab Average Price by Antibody Type (2021-2032) & (US$/Unit)
Figure 63. World Elrantamab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 64. World Elrantamab Production Value Market Share by Application in 2025
Figure 65. Monotherapy for Relapsed or Refractory Multiple Myeloma
Figure 66. Combination Therapy with Immunomodulators and Proteasome Inhibitors
Figure 67. Exploration in First-Line or Second-Line Treatment of Multiple Myeloma
Figure 68. Otherts
Figure 69. World Elrantamab Production Market Share by Application (2021-2032)
Figure 70. World Elrantamab Production Value Market Share by Application (2021-2032)
Figure 71. World Elrantamab Average Price by Application (2021-2032) & (US$/Unit)
Figure 72. Elrantamab Industry Chain
Figure 73. Elrantamab Procurement Model
Figure 74. Elrantamab Sales Model
Figure 75. Elrantamab Sales Channels, Direct Sales, and Distribution
Figure 76. Methodology
Figure 77. Research Process and Data Source
Figure 1. Elrantamab Picture
Figure 2. World Elrantamab Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Elrantamab Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Elrantamab Production (2021-2032) & (Units)
Figure 5. World Elrantamab Average Price (2021-2032) & (US$/Unit)
Figure 6. World Elrantamab Production Value Market Share by Region (2021-2032)
Figure 7. World Elrantamab Production Market Share by Region (2021-2032)
Figure 8. North America Elrantamab Production (2021-2032) & (Units)
Figure 9. Europe Elrantamab Production (2021-2032) & (Units)
Figure 10. China Elrantamab Production (2021-2032) & (Units)
Figure 11. Japan Elrantamab Production (2021-2032) & (Units)
Figure 12. India Elrantamab Production (2021-2032) & (Units)
Figure 13. Elrantamab Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Elrantamab Consumption (2021-2032) & (Units)
Figure 16. World Elrantamab Consumption Market Share by Region (2021-2032)
Figure 17. United States Elrantamab Consumption (2021-2032) & (Units)
Figure 18. China Elrantamab Consumption (2021-2032) & (Units)
Figure 19. Europe Elrantamab Consumption (2021-2032) & (Units)
Figure 20. Japan Elrantamab Consumption (2021-2032) & (Units)
Figure 21. South Korea Elrantamab Consumption (2021-2032) & (Units)
Figure 22. ASEAN Elrantamab Consumption (2021-2032) & (Units)
Figure 23. India Elrantamab Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Elrantamab by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Elrantamab Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Elrantamab Markets in 2025
Figure 27. United States VS China: Elrantamab Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Elrantamab Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Elrantamab Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Elrantamab Production Market Share 2025
Figure 31. China Based Manufacturers Elrantamab Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Elrantamab Production Market Share 2025
Figure 33. World Elrantamab Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Elrantamab Production Value Market Share by Type in 2025
Figure 35. 44 mg / 1.1 mL
Figure 36. 76 mg / 1.9 mL
Figure 37. World Elrantamab Production Market Share by Type (2021-2032)
Figure 38. World Elrantamab Production Value Market Share by Type (2021-2032)
Figure 39. World Elrantamab Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Elrantamab Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 41. World Elrantamab Production Value Market Share by Dosage Form in 2025
Figure 42. Subcutaneous Injection Solution
Figure 43. Lyophilized Powder for Injection
Figure 44. World Elrantamab Production Market Share by Dosage Form (2021-2032)
Figure 45. World Elrantamab Production Value Market Share by Dosage Form (2021-2032)
Figure 46. World Elrantamab Average Price by Dosage Form (2021-2032) & (US$/Unit)
Figure 47. World Elrantamab Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 48. World Elrantamab Production Value Market Share by Sales Channels in 2025
Figure 49. Hospital
Figure 50. Retail
Figure 51. Online
Figure 52. World Elrantamab Production Market Share by Sales Channels (2021-2032)
Figure 53. World Elrantamab Production Value Market Share by Sales Channels (2021-2032)
Figure 54. World Elrantamab Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 55. World Elrantamab Production Value by Antibody Type, (USD Million), 2021 & 2025 & 2032
Figure 56. World Elrantamab Production Value Market Share by Antibody Type in 2025
Figure 57. Monoclonal Antibody
Figure 58. Polyclonal Antibody
Figure 59. Bispecific Antibody
Figure 60. World Elrantamab Production Market Share by Antibody Type (2021-2032)
Figure 61. World Elrantamab Production Value Market Share by Antibody Type (2021-2032)
Figure 62. World Elrantamab Average Price by Antibody Type (2021-2032) & (US$/Unit)
Figure 63. World Elrantamab Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 64. World Elrantamab Production Value Market Share by Application in 2025
Figure 65. Monotherapy for Relapsed or Refractory Multiple Myeloma
Figure 66. Combination Therapy with Immunomodulators and Proteasome Inhibitors
Figure 67. Exploration in First-Line or Second-Line Treatment of Multiple Myeloma
Figure 68. Otherts
Figure 69. World Elrantamab Production Market Share by Application (2021-2032)
Figure 70. World Elrantamab Production Value Market Share by Application (2021-2032)
Figure 71. World Elrantamab Average Price by Application (2021-2032) & (US$/Unit)
Figure 72. Elrantamab Industry Chain
Figure 73. Elrantamab Procurement Model
Figure 74. Elrantamab Sales Model
Figure 75. Elrantamab Sales Channels, Direct Sales, and Distribution
Figure 76. Methodology
Figure 77. Research Process and Data Source
